CELIA, Christian
 Distribuzione geografica
Continente #
NA - Nord America 3.686
EU - Europa 3.260
AS - Asia 2.104
SA - Sud America 158
AF - Africa 14
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.237
Nazione #
US - Stati Uniti d'America 3.664
IT - Italia 941
SG - Singapore 844
CN - Cina 768
IE - Irlanda 583
UA - Ucraina 460
TR - Turchia 307
SE - Svezia 306
FR - Francia 181
DE - Germania 176
GB - Regno Unito 174
BR - Brasile 138
FI - Finlandia 122
RU - Federazione Russa 96
AT - Austria 57
IN - India 56
PL - Polonia 47
BE - Belgio 38
KR - Corea 25
VN - Vietnam 24
NL - Olanda 23
JP - Giappone 19
CA - Canada 17
HK - Hong Kong 17
RO - Romania 16
IR - Iran 10
AU - Australia 8
EG - Egitto 6
TH - Thailandia 6
AR - Argentina 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
EE - Estonia 5
ES - Italia 5
EU - Europa 5
LT - Lituania 5
PK - Pakistan 5
CL - Cile 4
MX - Messico 4
PH - Filippine 4
PT - Portogallo 4
CO - Colombia 3
EC - Ecuador 3
SA - Arabia Saudita 3
TW - Taiwan 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BD - Bangladesh 2
GM - Gambi 2
GR - Grecia 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
VE - Venezuela 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.237
Città #
Jacksonville 659
Dublin 570
Chandler 560
Singapore 465
Chieti 311
Princeton 294
Nanjing 220
Dearborn 181
Izmir 169
Ashburn 139
Wilmington 137
Southend 118
Beijing 116
Altamura 108
Santa Clara 106
The Dalles 104
Cambridge 101
Ann Arbor 95
Nanchang 67
Los Angeles 59
Vienna 46
Kunming 43
Woodbridge 41
Kraków 38
Pescara 35
Boardman 34
Rome 32
Tianjin 30
Hebei 27
Shenyang 27
Teramo 27
Houston 26
Washington 26
Helsinki 23
Jiaxing 23
Norwalk 23
Dong Ket 22
Falls Church 21
Hangzhou 21
Brussels 20
Council Bluffs 19
New York 19
Changsha 17
Nuremberg 15
Hong Kong 14
San Vito Chietino 14
Shanghai 14
Lochristi 13
Hefei 12
Milan 11
Wuhan 11
Catanzaro 10
Bologna 8
Catania 8
Lanzhou 8
Seoul 8
Toronto 8
Zhengzhou 8
Changchun 7
Munich 7
Seattle 7
Belo Horizonte 6
Genova 6
Guangzhou 6
Gävle 6
North Bergen 6
Parma 6
Redwood City 6
São Paulo 6
Berlin 5
Blacksburg 5
Brno 5
Falkenstein 5
Jinan 5
Lappeenranta 5
Naples 5
Roseto Degli Abruzzi 5
Simi Valley 5
Taranto 5
Termoli 5
Andover 4
Anoia Superiore 4
Belfast 4
Cagliari 4
Clifton 4
Copenhagen 4
Coventry 4
Frankfurt am Main 4
Grevenbroich 4
Kolkata 4
Montesilvano Marina 4
Ningbo 4
Notaresco 4
Porto Alegre 4
Rio de Janeiro 4
Rocca di Cambio 4
San Francisco 4
San Giovanni 4
São José dos Campos 4
Taizhou 4
Totale 5.585
Nome #
Laser diffraction and light scattering techniques for the analysis of food matrices 293
Lactobacillus reuteri:production and characterization of membrane vesicles for future health applications 166
Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938 138
Sistemi vescicolari formati da bilayer asimmetrici a struttura doppia per la veicolazione di materiale genetico. 122
Detection and characterization of Lactobacillus reuteri DSM 17938 Membrane Vesicles (MVs) from biofilm and planktonic phenotypes 120
Analysis of imidazoles and triazoles in biological samples after MicroExtraction by Packed Sorbent 118
An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers 117
Detection and quantification of eDNA-associated bacterial membrane vesicles by flow cytometry 114
MEPS-HPLC-PDA DETERMINATION OF TWELVE AZOLES DRUGS IN HUMAN PLASMA AND URINE 108
Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach 108
Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA). 106
Bioactive isoflavones from Pueraria lobata root and starch: different extraction techniques and carbonic anhydrase inhibition 105
Bioactive isoflavones from Pueraria lobata root and starch: Different extraction techniques and carbonic anhydrase inhibition 104
Acronychiabaueri Analogue Derivative-Loaded Ultradeformable Vesicles: Physicochemical Characterization and Potential Applications. 104
IL-MAE, UAE ED ESTRAZIONE CONVENZIONALE DI COMPOSTI BIOATTIVI IN RADICI DI PUERARIA LOBATA E VALUTAZIONE DELLA LORO ATTIVITÀ INIBITORIA SU ISOFORME DI ANIDRASI CARBONICA 102
Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery 101
Analytical Chemistry: Developments, Applications and Challenges in food analysis 100
Simultaneous determination of Gemcitabine Hydrochloride and Irinotecan Hydrochloride in rat plasma by high performance liquid chromatography-diode array detector 98
Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals. 97
Diameters and Fluorescence Calibration for Extracellular Vesicle Analyses by Flow Cytometry 96
Mild hyperthermia enhances transport of liposomal gemcitabine and improves in vivo therapeutic response 95
Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response. 94
Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications. 94
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy 93
HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples 91
Physicochemical Characterization of pH-responsive and Fusogenic Self-assembled Non-phospholipid Vesicles for a Potential Multiple Targeting Therapy 91
Penetration Enhancer-Containing Vesicles: Does the Penetration Enhancer Structure Affect Topical Drug Delivery? 89
PHARMACOKINETICS OF GEMCITABINE HYDROCHLORIDE AND IRINOTECAN HYDROCHLORIDE ALONE AND IN COMBINATION IN RAT PLASMA BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-DIODE ARRAY DETECTOR 89
Current trends in simultaneous determination of co-administered drugs 89
Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation. 87
Bergamot essential oil (BEO)-loaded liposomes: nanoformulation for anticancer activity on neuroblastoma cells 85
Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems 85
Super stealth liposomes for anticancer therapy 84
Determinazione in campioni biologici di sonde fluorescent veicolate in strutture vescicolari non fosfolipidiche mediante HPLC-FLD e spettrofotometria 82
Ultradeformable liposomes for potential delivery of natural products 82
Physicochemicel charecterization of non ionic surfactant vesicle forming innovative supramolecular nanocarriers 81
Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography-diode array detector 81
Cell Membrane-Based Nanoreactor To Mimic the Bio-Compartmentalization Strategy of a Cell. 81
Effect of three monoglyceride based cubosomes systems on the viability of human keratinocytes 80
Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models 80
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 80
Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent. 79
Hierarchical Microplates as Drug Depots with Controlled Geometry, Rigidity, and Therapeutic Efficacy. 78
Regenerative properties of aloe vera juice on human keratinocyte cell culture. 76
Analytical Methods to Best Detect Fluorescent Probe Loading Nanoparticles in Biological Samples 76
Hesperetin liposomes for cancer therapy. 75
Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulations 74
Anticancer Activity of Liposomal Bergamot Essential Oil (BEO) on Human Neuroblastoma Cells 74
Determinazione di Ciprofloxacina e Levofloxacina in espettorato da pazienti affetti da fibrosis cistica mediante MEPS-HPLC-PDA 73
Multistage vector delivery of sulindac and silymarin for prevention of colon cancer. 73
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 73
Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples 73
Retinoids: new use by innovative drug-delivery systems. 73
Supramolecular devices to improve the treatment of brain diseases. 72
Simultaneous determination of Eperisone Hydrochloride and Paracetamol in mouse plasma by high performance liquid chromatography-photodiode array detector 72
Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors. 72
Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate. 72
Polydocanol foam stabilized by liposomes: Supramolecular nanoconstructs for sclerotherapy. 72
pH-responsive cationic liposome for endosomal escape mediated drug delivery. 72
MEPS-HPLC-PDA ASSAY FOR CIPROFLOXACIN AND LEVOFLOXACIN IN HUMAN CYSTIC FIBROSIS PATIENTS SPUTUM DETERMINATION 71
Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy. 71
Colloidal supramolecular aggregates for therapeutic application in neuromedicine 70
Long Term Stability Evaluation of Prostacyclin Released from Biomedical Device through Turbiscan Lab Expert 69
Method validation and hyphenated techniques: recent trends and future perspectives 69
Paclitaxel-loaded ethosomes®: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses 69
In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis. 69
Sustained zero-order release of intact ultra-stable drug-loaded liposomes from an implantable nanochannel delivery system 68
Nanoliposomes as multidrug therapy for anticancer treatment 68
Colloidal carriers for the enhanced delivery through the skin. 68
Niosomes from 80s to present: The state of the art 67
Shrinkage of pegylated and non-pegylated liposomes in serum 67
Anticancer activity of all-trans retinoic acid-loaded liposomes on human thyroid carcinoma cells. 67
Ethosomes® and transfersomes® containing linoleic acid: Physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders 66
A novel animal model to evaluate the ability of a drug delivery system to promote the passage through the BBB. 66
In vitro evaluation of the activity of gemcitabine-loaded pegylated unilamellar liposomes against papillary thyroid cancer cells. 65
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes 65
MicroExtraction by Packed Sorbent and HPLC-PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine 65
Niosomes as Drug Nanovectors: Multiscale pH-dependent Structural Response. 65
Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles. 64
Quantitative Analysis Of Eperisone Hydrochloride And Paracetamol In Mouse Plasma By Using HPLC-PDA 64
Shrinkage of pegylated and non pegylated liposomes in biological fluid. 63
Bisphosphonate–polyaspartamide conjugates as bone targeted drug delivery systems 62
Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes 62
Satureja montana l. Essential oils: Chemical profiles/phytochemical screening, antimicrobial activity and o/w nanoemulsion formulations 62
Nanotherapeutics for anti-inflammatory delivery. 61
Celastrol-loaded liposomes as nano-drugs for the potential treatment of prostate cancer 61
Sclareol-loaded hyaluronan-coated PLGA nanoparticles: Physico-chemical properties and in vitro anticancer features 60
Overcoming Nanoparticle-Mediated Complement Activation by Surface PEG-Pairing. 60
Nanoparticulate devices for brain drug delivery. 59
Mortality and flexible ureteroscopy: analysis of six cases. 59
Nanoformulations of bergamot essential oil for in vitro anti neuroblastoma treatment 58
Paclitaxel-loaded sodium deoxycholate-stabilized zein nanoparticles: characterization and in vitro cytotoxicity. 58
Pulmonary glucocorticoid delivery by means of non phospholipid liposomes. 57
Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model. 57
Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. 56
Liposomal chemotherapeutics. 56
Penetration enhancer containing vesicles (PEVS) for dermal delivery of lidocaine. 54
Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. 54
Morphological and structural investigation of pH sensitive nanotherapeutics. 53
LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy 53
Totale 8.137
Categoria #
all - tutte 47.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020192 0 0 0 0 0 0 0 0 0 0 152 40
2020/2021855 131 20 147 15 47 147 54 28 75 95 27 69
2021/2022660 20 15 11 38 30 17 20 66 109 44 75 215
2022/20231.834 177 235 93 170 163 344 134 126 272 26 37 57
2023/2024988 63 37 56 34 63 268 212 60 20 59 29 87
2024/20251.914 177 390 256 82 78 106 77 162 388 148 50 0
Totale 10.210